Abbott Laboratories in its revolving credit facility

On January 29, 2024, Abbott Laboratories entered into a five-year $5.0 billion unsecured revolving credit facility with the lenders party thereto and JPMorgan Chase Bank, N.A. as administrative agent. 

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Abbott.